Ansamycins produced by Streptomyces sp. LZ35

Chinese Pharmaceutical Journal

Volumn 46, Issue 17, 2011, Pages 1317-1320

  Shi, Niu Niu ^a,b   Wang, Hao Xin ^a   Lu, Chun Hua ^c   Liu, Zui ^a   Shen, Yue Mao ^c  

^a XIAMEN UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Ansamycins; Column chromatography; Marine actinomycetes; Streptomyces sp.; Structural identification

Indexed keywords

17 O DEMETHYLGELDANAMYCIN; 17 O DEMETHYLREBLASTATIN; ANSAMYCIN DERIVATIVE; AUTOLYTIMYCIN; GELDANAMYCIN; HERBIMYCIN; HYGROCIN A DERIVATIVE; REBLASTATIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; STREPTOMYCES;

EID: 80355123810     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. KNOLL W M, RINEHART K L J, WILEY P F, et al. Streptovaricin U, an acyclic ansamycin [J]. J Antibiot (Tokyo), 1980, 33(2): 249-251.
2. MUKHOPADHYAY T, FRANCO C M, REDDY G C, et al. A new ansamycin antibiotic, naphthomycin H from a Streptomyces species Y-83, 40369 [J]. J Antibiot (Tokyo), 1985, 38(7): 948-951.
3. FUNAYAMA S, OKADA K, KOMIYAMA K, et al. Structure of trienomycin A, a novel cytocidal ansamycin antibiotic [J]. J Antibiot (Tokyo), 1985, 38(8): 1107-1109.
4. NOWAKOWSKI G S, MCCOLLUM A K, AMES M M, et al. A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer [J]. Clin Cancer Res, 2006, 12(20 Pt 1): 6087-6093.
5. PANARSKY R, REICHERT F, BEN-ISHAY Z. Effectiveness of 17-DMAG, a geldanamycin derivative, in murine acute myeloid leukemia [J]. Acta Haematol, 2009, 121(1): 32-36.
6. IKEDA H, HIDESSHIMA T, FULCINITI M, et al. The monoclonal antibody nBT062 conjugated to cytotoxic maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo[J]. Clin Cancer Res, 2009, 15(12): 4028-4037.
7. LI Z X, ZHANG M N, REN S, et al. Progress of clinical pharmacological study on rifabutin [J]. Chin J Clin Pharmacol Ther, 2006, 11(1): 1-9.
8. COHN H D. Clinical studies with a new rifamycin derivative [J]. J Clin Pharmacol, 1969, 9(2): 118-125.
9. DEBOER C, MEULMAN P A, WNUK R J, et al. Geldanamycin, a new antibiotic [J]. J Antibiot (Tokyo), 1970, 23(9): 442-447.
10. RINEHART K L Jr, SHIELD L S. Chemistry of the ansamycin antibiotics [J]. Fortschr Chem Org Naturst, 1976, 33: 231-307.
11. IWAI Y, NAKAGAWA A, SADAKANE N, et al. Herbimycin B, a new benzoquinonoid ansamycin with anti-TMV and herbicidal activities [J]. J Antibiot (Tokyo), 1980, 33(10): 1114-1119.
12. TAKATSU T, OHTSUKI M, MURAMATSU A, et al. Reblastatin, a novel benzenoid ansamycin-type cell cycle inhibitor [J]. J Antibiot (Tokyo), 2000, 53(11): 1310-1312.
13. LI M, WU H, ZHAO L, et al. Isolation and structure elucidation of autolytimycin, a new compound produced by Streptomyces autolyticus JX-47 [J]. Chin Chem Lett, 2001, 12(10): 903-906.
14. CAI P, KONG F, RUPPEN M E, et al. Hygrocins A and B, naphthoquinone macrolides from Streptomyces hygroscopicus [J]. J Nat Prod, 2005, 68(12): 1736-1742.